European And Australian Medical Cannabis Markets Will Unlock Enduring Potential

Published
26 Apr 25
Updated
15 Aug 25
AnalystConsensusTarget's Fair Value
CA$7.93
11.7% undervalued intrinsic discount
15 Aug
CA$7.00
Loading
1Y
-26.7%
7D
13.5%

Author's Valuation

CA$7.9

11.7% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on07 Aug 25
Fair value Decreased 5.93%

Despite substantial improvement in net profit margin and a sharply reduced future P/E ratio, the consensus analyst price target for Aurora Cannabis has decreased from CA$8.42 to CA$7.92. What's in the News Aurora Cannabis expects year-over-year net revenue growth in Q2 2026, primarily driven by an 8%–12% increase in its Global Medical Cannabis segment (Corporate Guidance – New/Confirmed, 2025-08-06).

Shared on01 May 25
Fair value Decreased 8.82%